Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
Luciferase | 6 | 0 | 0 | 6 |
glp-1 receptor, partial | 6 | 0 | 0 | 6 |
hypoxia-inducible factor 1 alpha subunit | 10 | 0 | 0 | 10 |
RAR-related orphan receptor gamma | 16 | 0 | 0 | 16 |
ATAD5 protein, partial | 5 | 0 | 0 | 5 |
Fumarate hydratase | 4 | 0 | 0 | 4 |
TDP1 protein | 13 | 0 | 0 | 13 |
GLI family zinc finger 3 | 15 | 0 | 0 | 15 |
AR protein | 19 | 0 | 0 | 19 |
caspase 7, apoptosis-related cysteine protease | 5 | 0 | 0 | 5 |
nuclear receptor subfamily 1, group I, member 3 | 14 | 0 | 0 | 14 |
progesterone receptor | 12 | 0 | 0 | 12 |
glucocorticoid receptor [Homo sapiens] | 13 | 0 | 0 | 13 |
retinoic acid nuclear receptor alpha variant 1 | 20 | 0 | 0 | 20 |
retinoid X nuclear receptor alpha | 16 | 0 | 0 | 16 |
estrogen-related nuclear receptor alpha | 20 | 0 | 0 | 20 |
farnesoid X nuclear receptor | 14 | 0 | 0 | 14 |
pregnane X nuclear receptor | 16 | 0 | 0 | 16 |
estrogen nuclear receptor alpha | 24 | 0 | 0 | 24 |
polyprotein | 4 | 0 | 0 | 4 |
67.9K protein | 5 | 0 | 0 | 5 |
peroxisome proliferator activated receptor gamma | 12 | 0 | 0 | 12 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 13 | 0 | 0 | 13 |
caspase-3 | 5 | 0 | 0 | 5 |
IDH1 | 5 | 0 | 0 | 5 |
euchromatic histone-lysine N-methyltransferase 2 | 12 | 0 | 0 | 12 |
aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 9 | 0 | 0 | 9 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 12 | 0 | 0 | 12 |
nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
Histone H2A.x | 9 | 0 | 0 | 9 |
cellular tumor antigen p53 isoform a | 6 | 0 | 0 | 6 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 6 | 0 | 0 | 6 |
chromobox protein homolog 1 | 8 | 0 | 0 | 8 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 14 | 0 | 0 | 14 |
histone deacetylase 9 isoform 3 | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 9 | 0 | 0 | 9 |
mitogen-activated protein kinase 1 | 7 | 0 | 0 | 7 |
urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
plasminogen precursor | 4 | 0 | 0 | 4 |
urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
geminin | 16 | 0 | 0 | 16 |
Vif | 0 | 0 | 0 | 1 |
peripheral myelin protein 22 | 9 | 0 | 0 | 9 |
survival motor neuron protein isoform d | 8 | 0 | 0 | 8 |
muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 12 | 0 | 0 | 12 |
neuropeptide S receptor isoform A | 4 | 0 | 0 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 11 | 0 | 11 |
Multidrug resistance-associated protein 4 | 0 | 11 | 0 | 11 |
Voltage-dependent calcium channel gamma-2 subunit | 12 | 0 | 0 | 12 |
Bile salt export pump | 0 | 13 | 0 | 13 |
Interferon beta | 9 | 0 | 0 | 9 |
Cellular tumor antigen p53 | 13 | 0 | 0 | 13 |
Integrin beta-3 | 4 | 1 | 0 | 5 |
Integrin alpha-IIb | 4 | 1 | 0 | 5 |
Methionine aminopeptidase | 0 | 3 | 0 | 3 |
Glutamate receptor 2 | 12 | 0 | 0 | 12 |
Fatty-acid amide hydrolase 1 | 0 | 3 | 0 | 3 |
Inositol monophosphatase 1 | 6 | 0 | 0 | 6 |
Canalicular multispecific organic anion transporter 1 | 0 | 11 | 0 | 11 |
ATPase family AAA domain-containing protein 5 | 7 | 0 | 0 | 7 |
Ataxin-2 | 9 | 0 | 0 | 9 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 7 | 0 | 0 | 7 |
Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
Chain A, Cruzipain | 6 | 0 | 0 | 6 |
Beta-lactamase | 0 | 0 | 0 | 2 |
acid sphingomyelinase | 2 | 0 | 0 | 2 |
GLS protein | 6 | 0 | 0 | 6 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
DNA polymerase beta | 4 | 0 | 0 | 4 |
DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
Carbonic anhydrase 1 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 3 | 0 | 3 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 1 | 0 | 4 | 0 | 4 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Spike glycoprotein | 8 | 1 | 1 | 10 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 3 |
Efflux transporter | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Class D beta-lactamase | 0 | 0 | 0 | 1 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
Metallo-b-lactamase | 0 | 0 | 0 | 3 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 0 | 0 | 2 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 3 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 3 |
ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 5 | 0 | 0 | 5 |
Chain B, HADH2 protein | 5 | 0 | 0 | 5 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 5 | 0 | 0 | 5 |
thioredoxin reductase | 6 | 0 | 0 | 6 |
aldehyde dehydrogenase 1 family, member A1 | 10 | 0 | 0 | 10 |
thyroid stimulating hormone receptor | 11 | 0 | 0 | 11 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 12 | 0 | 0 | 12 |
EWS/FLI fusion protein | 7 | 0 | 0 | 7 |
cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
glucocerebrosidase | 4 | 0 | 0 | 4 |
peroxisome proliferator-activated receptor delta | 10 | 0 | 0 | 10 |
Rac1 protein | 0 | 0 | 1 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
Bloom syndrome protein isoform 1 | 6 | 0 | 0 | 6 |
muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
lethal factor (plasmid) | 7 | 0 | 0 | 7 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 1 | 1 | 0 | 2 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 5 | 0 | 0 | 5 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 8 | 1 | 0 | 9 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
pregnane X receptor | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 15 | 0 | 0 | 15 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Albumin | 0 | 0 | 2 | 2 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
Chain A, Ferritin light chain | 6 | 0 | 0 | 6 |
acetylcholinesterase | 7 | 0 | 0 | 7 |
SMAD family member 2 | 9 | 0 | 0 | 9 |
USP1 protein, partial | 8 | 0 | 0 | 8 |
SMAD family member 3 | 9 | 0 | 0 | 9 |
Microtubule-associated protein tau | 7 | 0 | 0 | 7 |
estrogen receptor 2 (ER beta) | 12 | 0 | 0 | 12 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 9 | 0 | 0 | 9 |
thyrotropin-releasing hormone receptor | 4 | 0 | 0 | 4 |
vitamin D3 receptor isoform VDRA | 6 | 0 | 0 | 6 |
nuclear receptor ROR-gamma isoform 1 | 5 | 0 | 0 | 5 |
Caspase-2 | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
PAX8 | 0 | 0 | 0 | 2 |
15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
PINK1 | 3 | 0 | 0 | 3 |
G | 7 | 0 | 0 | 7 |
Parkin | 3 | 0 | 0 | 3 |
heat shock protein 90 | 0 | 0 | 2 | 2 |
calcineurin A1, putative | 0 | 0 | 1 | 1 |
thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 11 | 0 | 0 | 11 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
perilipin-5 | 0 | 1 | 0 | 1 |
thyroid hormone receptor beta isoform a | 8 | 0 | 0 | 8 |
perilipin-1 | 0 | 1 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 5 | 0 | 0 | 5 |
huntingtin isoform 2 | 4 | 0 | 0 | 4 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 3 | 0 | 0 | 3 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
melanocortin receptor 4 | 0 | 1 | 0 | 1 |
CAAX prenyl protease | 0 | 0 | 0 | 1 |
bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 8 | 0 | 0 | 8 |
glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
hexokinase HKDC1 | 0 | 1 | 0 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 8 | 0 | 0 | 8 |
Synaptojanin-2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 4 | 0 | 0 | 4 |
Synaptojanin-1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 7 | 0 | 0 | 7 |
72 kDa type IV collagenase | 0 | 2 | 0 | 2 |
Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit delta | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 8 | 0 | 0 | 8 |
Trypanothione reductase | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 8 | 0 | 0 | 8 |
Alpha-synuclein | 3 | 1 | 0 | 4 |
Histamine H2 receptor | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-3 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit beta-2 | 8 | 0 | 0 | 8 |
TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
GABA theta subunit | 8 | 0 | 0 | 8 |
Inositol hexakisphosphate kinase 1 | 7 | 0 | 0 | 7 |
Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit epsilon | 8 | 0 | 0 | 8 |
Spermine oxidase | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 7 | 0 | 0 | 7 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
Protein-arginine deiminase type-4 | 0 | 7 | 0 | 7 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Beta-lactamase TEM | 0 | 1 | 0 | 1 |
Caspase-7 | 3 | 0 | 0 | 3 |
caspase-3 | 3 | 0 | 0 | 3 |
Androgen receptor | 0 | 3 | 0 | 3 |
endonuclease IV | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
Hsf1 protein | 0 | 0 | 1 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
calpain II, partial | 0 | 1 | 0 | 1 |
SUMO-1 | 0 | 1 | 0 | 1 |
Mcl-1 | 0 | 1 | 0 | 1 |
Valosin-containing protein | 0 | 1 | 0 | 1 |
TSHR protein | 1 | 0 | 0 | 1 |
Estrogen receptor 1 | 0 | 1 | 0 | 1 |
Smad3 | 2 | 0 | 0 | 2 |
envelope glycoprotein | 0 | 1 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
heat shock 70kDa protein 1A | 0 | 1 | 0 | 1 |
galactokinase | 2 | 0 | 0 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 3 | 0 | 0 | 3 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
neuropeptide Y receptor type 1 | 0 | 0 | 1 | 1 |
neuropeptide Y receptor type 2 | 0 | 0 | 1 | 1 |
small ubiquitin-related modifier 2 isoform b precursor | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
estrogen receptor beta isoform 1 | 0 | 2 | 0 | 2 |
enteropeptidase precursor | 1 | 0 | 0 | 1 |
fatty acid synthase | 0 | 1 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 3 |
heat shock cognate 71 kDa protein isoform 1 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
Vpr | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinase | 1 | 0 | 0 | 1 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
exodeoxyribonuclease V subunit RecD | 0 | 2 | 0 | 2 |
exodeoxyribonuclease V subunit RecB | 0 | 2 | 0 | 2 |
exodeoxyribonuclease V subunit RecC | 0 | 2 | 0 | 2 |
POsterior Segregation | 0 | 0 | 1 | 1 |
heat shock cognate 71 kDa protein isoform 2 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
Estrogen receptor | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 4 | 0 | 4 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 2 | 1 | 3 |
Replicase polyprotein 1ab | 0 | 3 | 1 | 4 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Replicase polyprotein 1ab | 0 | 3 | 2 | 5 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Endoplasmic reticulum chaperone BiP | 0 | 2 | 0 | 2 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 3 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 4 | 0 | 4 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 1 | 3 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
Caspase-7 | 1 | 0 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | 0 | 1 | 0 | 1 |
N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | 0 | 1 | 0 | 1 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 2 |
M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
BZLF2 | 0 | 1 | 0 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
PPM1D protein | 3 | 0 | 0 | 3 |
Tyrosine-protein kinase ABL1 | 0 | 2 | 0 | 2 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 2 | 0 | 2 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Calmodulin-domain protein kinase 1 | 0 | 1 | 0 | 1 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 2 | 0 | 2 |
Matrilysin | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 2 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 4 | 1 | 5 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 3 | 0 | 0 | 1 | 1 |
Nicotinamidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 0 | 1 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 2 | 1 | 3 |
D-aspartate oxidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 1 | 1 | 2 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
arylsulfatase A | 1 | 0 | 0 | 1 |
karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b | 0 | 0 | 1 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
Spike glycoprotein | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
Transmembrane protease serine 2 | 0 | 1 | 1 | 2 |
Major prion protein | 0 | 0 | 1 | 1 |
Procathepsin L | 0 | 1 | 1 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Calmodulin-1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
Histamine H1 receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Calmodulin | 0 | 0 | 1 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 1 | 1 | 2 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Sphingosine kinase 2 | 0 | 2 | 0 | 2 |
Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase (fumarate) | 0 | 1 | 0 | 1 |
Acyl carrier protein, mitochondrial | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
ATP-dependent 6-phosphofructokinase | 0 | 1 | 0 | 1 |
Dihydropteroate synthase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 3 | 0 | 4 |
Endothelin-1 receptor | 1 | 1 | 0 | 2 |
Protease | 0 | 1 | 1 | 2 |
polyadenylate-binding protein 1 | 0 | 1 | 0 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
BRCA1 | 1 | 0 | 0 | 1 |
P53 | 1 | 0 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
Endothelin receptor type B | 1 | 0 | 0 | 1 |
Methionine aminopeptidase 2 | 0 | 1 | 0 | 1 |
Methionine aminopeptidase 1 | 0 | 1 | 1 | 2 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 0 | 1 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, Repressor | 0 | 0 | 1 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
Transthyretin | 0 | 1 | 1 | 2 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 2 | 0 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | 0 | 2 | 0 | 2 |
Enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Enoyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
Enoyl-ACP reductase II | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate Reductase | 0 | 0 | 1 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, dihydrofolate reductase (DHFR) | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase type 1 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase type 1 from Tn4003 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Metabotropic glutamate receptor 5 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Trace amine-associated receptor 5 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
Guanine deaminase | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |